Table 2 |
|||
|
Inhibition of HIV-1 mediated cell-cell fusion by gp41 MPR derived peptides |
|||
| IC50g (nM, Mean ± S.D.) |
IC50 (nM, Mean ± S.D.) |
||
|
|
|||
| N36 |
>1000 |
LZ |
> 1000 |
| P1 |
913 ± 13.6 |
P1 + LZ |
923.4 ± 11.7 |
| T20 |
78 ± 5.6 |
T20 + LZ |
579 ± 3.5 |
| P5 |
60 ± 2. |
P5 + LZ |
61 ± 1.5 |
| P5L |
90 ± 1.7 |
P7 |
560 ± 10.7 |
|
|
|||
|
Note: Peptides P5L and P7 are recombinants the other chemically synthesized |
|||
|
Yu et al. Retrovirology 2008 5:93 doi:10.1186/1742-4690-5-93 |
|||
